Clinical Trial

Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace

Study acronym: PREFORTIC
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Ticks are blood-sucking arthropods that feed on vertebrate hosts. Although wild and domestic animals are the primary source of tick blood meals, humans can be an accidental host. During a blood meal, a microorganism can be transmitted to the host who can develop a disease. All infectious diseases transmitted by ticks are referred to as tick-borne diseases (TBDs). They are the most prevalent vector-borne diseases in the Northern Hemisphere. Among these diseases, Lyme borreliosis is the most common. In Europe, Lyme borreliosis does not cause high fevers (\> 38°C). Therefore, when a patient presents with a high fever with the notion of exposure to ticks, another etiology must be suspected. Anaplasma phagocytophilum and the tick-borne encephalitis virus are classically described as causing febrile syndromes. In France, ticks and tick-borne diseases are increasing, particularly those associated with the Ixodes ricinus tick. This tick is mainly present in forest ecosystems with a peak of activity in May. Foresters represent a population with biting ticks and tick-borne diseases, notably Lyme borreliosis.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06492668
Lead Sponsor University Hospital, Strasbourg, France
Conditions Lyme Borreliosis
Enrollment 20 participants
Start Date 2024-01-01
Primary Completion 2025-07 (estimated)
Study Completion 2025-07-08 (estimated)
Updated on ClinicalTrials.gov 2024-07-15